NCT07002125

Brief Summary

The aim of this interventional study is to investigate the effect of whole body vibration therapy on muscle oxygenation, vibration sensation, functional capacity and balance in individuals with Type 2 diabetes. The main questions aimed to be answered are:

  • Does whole body vibration therapy affect peripheral muscle oxygenation?
  • Does whole body vibration therapy improve vibration sense, functional capacity and balance compared to aerobic exercise? Participants' muscle oxygenation, vibration sensation, functional capacity and balance parameters will be assessed. They will participate in a whole body vibration therapy or aerobic training program.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable type-2-diabetes

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 17, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

June 3, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

August 26, 2025

Status Verified

August 1, 2025

Enrollment Period

4 months

First QC Date

May 17, 2025

Last Update Submit

August 25, 2025

Conditions

Keywords

Aerobic exercisediapasonbalanceHbA1ctype 2 diabeteswhole body vibrationmuscle oxygenation

Outcome Measures

Primary Outcomes (1)

  • Muscle Oxygenation

    Vastus lateralis muscle oxygenation will be evaluated with Near-Infrared Spectroscopy at rest, during and after the 6-Minute Walk Test (6MWT)

    8 weeks

Secondary Outcomes (5)

  • Vibration sense

    8 weeks

  • The Timed Up & Go Test

    8 weeks

  • The 6 minute walk test

    8 weeks

  • The 30-second Chair Stand Test

    8 weeks

  • Balance

    8 weeks

Study Arms (2)

Aerobic Exercise

EXPERIMENTAL

The aerobic exercise group (AE) will participate in an ascending aerobic exercise program for 8 weeks, 3 sessions per week.

Other: Aerobic Exercise

Whole Body Vibration

EXPERIMENTAL

The whole body vibration group (AE+TVV) will additionally participate in an 8-week incremental aerobic exercise program of 3 sessions per week.

Other: Whole Body VibrationOther: Aerobic Exercise

Interventions

Each exercise session will be performed with a frequency of 30 Hz and an amplitude of 2 mm. Participants are in a 110° squat position on the platform (the degree will be adjusted using a goniometer). Participants will exercise for 16 minutes from week one to week three, 20 minutes from week four to week six and 24 minutes from week seven to week eight, respectively (8 iterations and 1 minute of vibration with 1 minute interval between each iteration)

Whole Body Vibration

From week one to week three, from week four to week six and from week seven to week eight, the participants will exercise for 30 minutes (5 minutes of running at 60-70% of heart rate and 5 minutes of active rest at 30-45% of maximum heart rate), 42 minutes (7 minutes of running at 60-70% of heart rate and 7 minutes of active rest at 30-45% of maximum heart rate) and 60 minutes (10 minutes of running at 60-70% of heart rate and 10 minutes of active rest at 30-45% of maximum heart rate). The exercise sessions consist of warm-up, main program and cool-down phases.

Aerobic ExerciseWhole Body Vibration

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Volunteering to participate in the research
  • Being diagnosed with type 2 diabetes
  • years of age or older
  • HbA1c level to be 6.5-10%
  • Having a clinical history of diabetes between 2-10 years
  • Receiving oral hypoglycemic agent treatment
  • At least three HbA1c measurements within 12 to 24 months
  • Hemoglobin variability score (HVS) \<50
  • Being able to walk independently
  • Mini mental test score ≥ 24
  • Vastus lateralis muscle adipose tissue thickness \<20mm
  • BMI \<30 kg/m2

You may not qualify if:

  • Previous or concurrent psychiatric, neurological, orthopedic or systemic illness
  • Use of insulin in treatment
  • Diabetic neuropathy
  • Foot ulcer
  • Participation in any exercise program in the last 6 months
  • History of major hypoglycemia in the last 12 months
  • Working or have worked in a job with high exposure to mechanical whole body vibrations
  • Conditions that may contraindicate whole body vibration (deep vein thrombosis, severe osteoporosis, active cancer, implanted medical devices, etc.)
  • Hearing, vision and perception problems that may affect research results

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University, Faculty of Health, Department of Physiotherapy and Rehabilitation

Ankara, Çankaya, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Exercise

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Selcan Suicmez, Research Asst.

CONTACT

Zeynep Hazar, Prof. Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The study is planned as a triple-blind, randomized controlled trial. Patients will not be informed about their group. The assessment will be followed by 1 physiotherapist, and the exercise program will be followed by 2 physiotherapists (the physiotherapist performing the assessment is not included). Study groups will be coded before statistical analysis, and the meaning of the codes will not be told to the statistician.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Individuals with Type 2 diabetes who agreed to participate in the study will be divided into two groups as aerobic exercise group (AE) and whole body vibration group (AE+WBV).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 17, 2025

First Posted

June 3, 2025

Study Start

August 1, 2025

Primary Completion

December 1, 2025

Study Completion

December 31, 2025

Last Updated

August 26, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations